Multi-infarct disorder presenting as corticobasal degeneration (DCB): Vascular pseudo-corticobasal degeneration?;Infarctus cérébraux multiples se présentant comme une dégénérescence cortico-basale: Pseudo dégé nérescence cortico-basale vasculaire?

Revue Neurologique

Volumn 163, Issue 12, 2007, Pages 1191-1199

  Kreisler, A ^a   Mastain, B ^a   Tison, F ^b   Fenelon G ^c   Destee A ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Corticobasal degeneration; Magnetic resonance imaging; Vascular disease

Indexed keywords

ACETYLSALICYLIC ACID; LEVODOPA;

ADULT; AGED; ANAMNESIS; APRAXIA; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DISEASE COURSE; DYSTONIA; FEMALE; HUMAN; MYOCLONUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PHENOTYPE; PUBLICATION; SENSORY DYSFUNCTION; VASCULAR LESION;

EID: 38049125813     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)78403-5     Document Type: Article

References (48)

1. ARIMA K, UESUGI H, FUJITA I et al. (1994). Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies. J Neurol Sci, 127: 186-197.
2. BALLAN G, TISON F, DOUSSET V, VIDAILHET M, AGID Y, HENRY P. (1998). Étude de l'atrophie corticale par imagerie par résonance magnétique dans la dégénérescence cortico-basale. Rev Neurol (Paris), 154: 224-227.
3. BHATIA KP, LEE MS, RINNE JO, REVESZ T, SCARAVILLI F, DAVIES L, MARSDEN CD. (2000). Corticobasal degeneration look-alikes. In: Litvan I, Goetz CG, Lang AE (eds.), Corticobasal degeneration and related disorders. Philadelphia, Lippincott, Williams and Wilkins; pp. 169-182.
4. BLACK SE. (2000). Aphasia in corticobasal degeneration. In: Litvan I, Goetz CG, Lang AE (eds.), Corticobasal degeneration and related disorders. Philadelphia, Lippincott, Williams and Wilkins ; pp. 169-182.
5. BOEVE BF, MARANAGORE DM, PARISI JE, AHLSKOG JE, GRAFF-RADFORD N, CASELLI RJ, DICKSON DW, KOKMEN E, PETERSEN RC. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53: 795-800.
6. CASELLI RJ, JACK CR, PETERSEN RC, WAHNER HW, YANAGIHARA T. (1992). Asymmetric cortical degenerative syndromes: clinical and radiologic correlations. Neurology, 42: 1462-1468.
7. DUBINSKY RM, JANKOVIC J. (1987). Progressive supranuclear palsy and a multi-infarct state. Neurology, 37: 570-576.
8. FÉNELON G, HOUÉTO JL (1998). Les syndromes parkinsoniens vasculaires : un concept controversé. Rev Neurol (Paris), 154: 291-302.
9. GAIG C, MARTI MJ, TOLOSA E et al. (2006). 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov Disord, 21: 1194-1198.
10. GIBB WRG, LUTHERT PJ, MARSDEN CD. (1989). Corticobasal degeneration. Brain, 112: 1171-1192.
11. GIMENEZ-ROLDÁN S, MATEO D, BENITO C, GRANDAS F, PÉREZ-GILABERT Y. (1994). Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm, 42: 79-90.
12. GRAHAM NL, BAK T, PATTERSON K, HODGES JR (2003). Language function and dysfunction in corticobasal degeneration. Neurology, 61: 493-499.
13. GRIMES DA, LANG AE, BERGERON CB. (1999). Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology, 53: 1969-1974.
14. GRISOLI M, FETONI V, SAVOIARDO M, GIROTTI F, BRUZZONE MG. (1995). MRI in corticobasal degeneration. Eur J Neurol, 53: 1969-1974.
15. HUGHES AJ, DANIEL SE, KILFORD L, LEES AJ. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry, 55: 181-184.
16. IKEDA K, KAKIGI R, FUNAI N, NESHIGE R, KURODA Y, SHIBASAKI H. (1990). Cortical tremor: a variant of cortical myoclonus. Neurology, 40: 1561-1565.
17. IKEDA K, AKIYAMA H, IRITANI S et al. (1996). Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol, 92: 534-539.
18. JOSEPHS KA, ISHIZAWA T, TSUBOI Y, COOKSON N, DICKSON DW. (2002). A clinicopathological study of vascular progressive supranuclear palsy: multi-infarct disorder presenting as progressive supranuclear palsy. Arch Neurol, 59: 1597-1601.
19. KLAFFKE S, KUHN AA, PLOTKIN M et al. (2006). Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Mov Disord, 21: 1724-1727.
20. KOMPOLITI K, GOETZ CG, BOEVE BF et al. (1998). Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol, 55: 957-961.
21. KREISLER A, DEFEBVRE L, LECOUFFE L et al. (2005). Corticobasal degeneration and Parkinson's disease assessed by HmPaO-SPECT: the utility of factorial discriminant analysis. Mov Disord, 20: 1431-1438.
22. rd. Baltimore, Williams and Wilkins ; pp. 297-316.
23. LANG AE, RILEY DE, BERGERON C. (1994). Cortical-basal ganglionic degeneration. In: Calne DB (ed.), Neurodegenerative diseases. Philadelphia, WB Saunders; pp. 877-894.
24. LEIGUARDA R, LEES AJ, MERELLO M, STARKSTEIN S, MARSDEN CD. (1994). The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry, 57: 455-459.
25. LITVAN I, AGID Y, GOETZ CG et al. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology, 48: 119-125.
26. LORBERBOYM M, DJALDETTI R, MELAMED E et al. (2004). (123I)-FPCIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med, 45: 1688-1693.
27. MARSHALL V, GROSSET D. (2003). Role of dopamine transporter imaging in routine clinical practice. Mov Disord, 18: 1415-1423.
28. MENDEZ MF (2000). Corticobasal ganglionic degeneration with Balint's syndrome. J Neuropsych Clin Neurosci, 12: 273-275.
29. MURROW RW, SCHWEIGER GD, KEPES JJ, KOLLER WC. (1990). Parkinsonism due to basal ganglia lacunar state: clinicopathologic correlation. Neurology, 40: 897-900.
30. OKUDA B, KODAMA N, TACHIBANA H, SUGITA M. (2000). Visuomotor ataxia in corticobasal degeneration. Mov Disord, 15: 337-339.
31. PEIGNEUX P, SALMON E, GARRAUX G et al. (2001). Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology, 57: 1159-1168.
32. PILLON B, BLIN J, VIDAILHET M, DEWEER B, SIRIGU A, DUBOIS B, AGID Y. (1995). The neuropsychological pattern of corticobasal degeneration. Comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology, 45: 1477-1483.
33. PIRKER W, ASSENBAUM S, BENCSITS S et al. (2000). (123I)B-CIT SPECT in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration. Mov Disord, 15: 1158-1167.
34. PLOTKIN M, AMTHAUER H, QUILL S et al. (2005). Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases. J Neural Transm, 112: 1355-1361.
35. REBEIZ JJ, KOLODNY EH, RICHARDSON EP (1967). Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc, 92: 23-26.
36. REY GJ, TOMER R, LEVIN BE, SANCHEZ-RAMOS J, BOWEN B, BRUCE JH. (1995). Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord, 10: 106-110.
37. RILEY DE, LANG AE, LEWIS A, RESCH L, ASHBY P, HORNYKIEWICZ O, BLACK S. (1990). Cortical-basal ganglionic degeneration. Neurology, 40: 1203-1212.
38. RINNE JO, LEE MS, THOMPSON PD, MARSDEN CD. (1994). Corticobasal degeneration. A clinical study of 36 cases. Brain, 117: 1183-1196.
39. SAVOIARDO M, GRISOLI M, GIROTTI F. (2000). Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. Adv Neurol, 82: 197-208.
40. SCHNEIDER JA, WATTS RL, GEARING M, BREWER RP, MIRRA SS. (1993). Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology, 48: 959-969.
41. SIBON I, FÉNELON G, QUINN NP, TISON F. (2004). Vascular parkinsonism. J Neurol, 251: 513-524.
42. SOLIVERI P, MONZA D, PARIDI D et al. (1999). Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology, 53: 502-507.
43. TOKUMARU AM, O'UCHI T, KURU Y, MAKI T, MURAYAMA S, HORICHI Y. (1996). Corticobasal degeneration: MR with histopathologic comparison. Am J Neuroradiol, 17: 1849-1852.
44. VAN GERPEN JA, AHLSKOG JE, PETTY GW. (2003). Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat D, 9: 367-369.
45. WENNING GK, LITVAN I, JANKOVIC J et al. (1998). Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry, 64: 184-189.
46. WINKELMANN J, AUER DP, LECHNER C, ELBEL G, TRENKWALDER C. (1999). Magnetic resonance imaging findings in corticobasal degeneration. Mov Disord, 14: 669-673.
47. WINIKATES J, JANKOVIC J. (1994). Vascular progressive supranuclear palsy. J Neural Transm Suppl, 42: 189-201.
48. YEKHLEF F, BALLAN G, MACIA F, DELMER O, SOURGEN C, TISON F. (2003). Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm, 110: 151-169.